NASDAQ: EVAX
Evaxion Biotech A Stock Ownership - Who owns Evaxion Biotech A?

Insider buying vs selling

Have Evaxion Biotech A insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when EVAX insiders and whales buy or sell their stock.

EVAX Shareholders

What type of owners hold Evaxion Biotech A stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Merck Co Inc0.77%542,279$709.84kInstitution
Armistice Capital LLC0.21%150,462$196.95kInstitution
Invst LLC0.07%50,400$65.97kInstitution
Catalina Capital Group LLC0.05%34,864$45.64kInstitution
Millennium Management LLC0.03%22,541$29.51kInstitution
Beacon Capital Management LLC0.01%4,863$6.37kInstitution
Jpmorgan Chase Co0.00%780$1.02kInstitution
Sbi Securities Co Ltd0.00%323$422.81Institution
Rhumbline Advisers0.00%290$379.61Institution
Southstate Corp0.00%4$5.24Institution

1 of 2

EVAX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
EVAX1.15%0.00%
ZVSA1.92%98.08%
ELAB0.15%99.85%
TNFA1.25%71.93%
ENTO1.26%98.74%Net Selling

Evaxion Biotech A Stock Ownership FAQ

Who owns Evaxion Biotech A?

Evaxion Biotech A (NASDAQ: EVAX) is owned by 1.15% institutional shareholders, 0.00% Evaxion Biotech A insiders, and 98.85% retail investors. Merck Co Inc is the largest individual Evaxion Biotech A shareholder, owning 542,279.00 shares representing 0.77% of the company. Merck Co Inc's Evaxion Biotech A shares are currently valued at $707.67k.

If you're new to stock investing, here's how to buy Evaxion Biotech A stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.